These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 108704)

  • 61. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 62. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Drug effects under automaintenance and negative automaintenance procedures.
    Poling A; Appel JB
    Pharmacol Biochem Behav; 1978 Sep; 9(3):315-8. PubMed ID: 714981
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 65. Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex.
    Lucki I; Minugh-Purvis N
    Brain Res; 1987 Sep; 420(2):403-6. PubMed ID: 2960422
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Antiserotonergic effect of antidepressives in quipazine-induced headshake behavior in the rat].
    Fischer W; Müller M
    Pharmazie; 1984 Nov; 39(11):776-7. PubMed ID: 6531385
    [No Abstract]   [Full Text] [Related]  

  • 67. Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task.
    Carli M; Samanin R
    Psychopharmacology (Berl); 1992; 106(2):228-34. PubMed ID: 1532259
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system.
    Dall'Olio R; Vaccheri A; Montanaro N
    Pharmacol Biochem Behav; 1985 Jul; 23(1):43-8. PubMed ID: 2994121
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
    Shukla R; MacKenzie-Taylor D; Rech RH
    Psychopharmacology (Berl); 1990; 100(1):115-8. PubMed ID: 2296618
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
    Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hallucinogens as discriminative stimuli.
    Winter JC
    Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
    [No Abstract]   [Full Text] [Related]  

  • 72. Serotonergic agonists stimulate inositol lipid metabolism in rabbit platelets.
    Schächter M; Godfrey PP; Minchin MC; McClue SJ; Young MM
    Life Sci; 1985 Oct; 37(17):1641-7. PubMed ID: 2997568
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats.
    Alper RH; Snider JM
    J Pharmacol Exp Ther; 1987 Dec; 243(3):829-33. PubMed ID: 3320345
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The use of drug discrimination procedures to characterize hallucinogenic drug actions.
    Appel JB; Cunningham KA
    Psychopharmacol Bull; 1986; 22(3):959-67. PubMed ID: 3797596
    [No Abstract]   [Full Text] [Related]  

  • 75. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
    White FJ; Appel JB
    Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aggressive behavior inhibition by serotonin and quipazine injected into the amygdala in the rat.
    Puciłowski O; Płaźnik A; Kostowski W
    Behav Neural Biol; 1985 Jan; 43(1):58-68. PubMed ID: 4039562
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 5-Methoxytryptamine: stimulation of 5-HT receptors mediating the rat hyperactivity syndrome and blood platelet aggregation.
    Boullin DJ; Green AR
    Adv Biochem Psychopharmacol; 1976; 15():127-40. PubMed ID: 15408
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of chronic administration of fenfluramine and quipazine on body weight gain after ovariectomy and on brain serotonin receptor binding.
    Rowland N; Carlton J; Bartness T; Smith G
    Behav Neurosci; 1983 Jun; 97(3):502-5. PubMed ID: 6683563
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.
    Dwoskin LP; Sparber SB
    J Pharmacol Exp Ther; 1983 Apr; 225(1):77-84. PubMed ID: 6834279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.